Madrid Institute for Advanced Studies (IMDEA)-Food, Laboratory of Epigenetics of Lipid Metabolism, Madrid, Spain.
Institute of Dairy Products of Asturias (IPLA-CSIC), Villaviciosa, Spain.
Br J Pharmacol. 2021 Jun;178(11):2218-2245. doi: 10.1111/bph.15421. Epub 2021 Mar 31.
Cross-kingdom communication via non-coding RNAs is a recent discovery. Exogenous microRNAs (exog-miRNAs) mainly enter the host via the diet. Generally considered unstable in the gastrointestinal tract, some exogenous RNAs may resist these conditions, especially if transported in extracellular vesicles. They could then reach the intestines and more probably exert a regulatory effect. We give an overview of recent discoveries concerning dietary miRNAs, possible ways of enhancing their resistance to food processing and gut conditions, their transport in extracellular vesicles (animal- and plant-origin) and possible biological effects on recipient cells after ingestion. We critically focus on what we believe are the most relevant data for future pharmacological development of dietary miRNAs as therapeutic agents. Finally, we discuss the miRNA-mediated cross-kingdom regulation between diet, host and the gut microbiota. We conclude that, despite many obstacles and challenges, extracellular miRNAs are serious candidates to be targeted pharmacologically for development of new therapeutic agents.
种间非编码 RNA 通讯是最近的发现。外源性 microRNAs(exog-miRNAs) 主要通过饮食进入宿主。通常认为在胃肠道中不稳定,一些外源性 RNA 可能抵抗这些条件,特别是如果在细胞外囊泡中运输。然后,它们可以到达肠道,并更有可能发挥调节作用。我们综述了最近关于饮食 miRNA 的发现,可能增强其对食物加工和肠道条件的抗性的方法,它们在细胞外囊泡(动物和植物来源)中的运输,以及摄入后对受体细胞可能产生的生物学效应。我们重点关注我们认为对未来作为治疗剂的饮食 miRNA 的药理学发展最相关的数据。最后,我们讨论了饮食、宿主和肠道微生物群之间 miRNA 介导的种间调控。我们得出结论,尽管存在许多障碍和挑战,但细胞外 miRNA 是作为药物靶点的有前途的候选者,可用于开发新的治疗药物。